Press release
Jun 20, 2011

Sosei Announces Collaboration with Gifu Pharmaceutical University


20 June 2011 Tokyo, Japan Sosei Group Corporation (“Sosei”, TSE Mothers Index: 4565) announced today that its wholly owned subsidiary Activus Pharma (“Activus”) entered the collaboration agreement with Gifu Pharmaceutical University to explore the potential of APNT (Activus Pure Nano-particle Technology) in treatment of ophthalmic diseases.

Under the terms of the agreement, the two parties will undergo the feasibility study required for the optimum formulation design. In case the positive data are obtained in this study, the further studies will be undertaken.


 DOWNLOAD PDF